Effects of a clinical decision support system and patient portal for preventing medication-related falls in older fallers: Protocol of a cluster randomized controlled trial with embedded process and economic evaluations (ADFICE_IT).

Autor: Kelly K de Wildt, Bob van de Loo, Annemiek J Linn, Stephanie K Medlock, Sara S Groos, Kim J Ploegmakers, Lotta J Seppala, Judith E Bosmans, Ameen Abu-Hanna, Julia C M van Weert, Natasja M van Schoor, Nathalie van der Velde, ADFICE_IT study team

Publikováno v: PLoS ONE, Vol 18, Iss 9, p e0289385 (2023)

BackgroundFalls are the leading cause of injury-related mortality and hospitalization among adults aged ≥ 65 years. An important modifiable fall-risk factor is use of fall-risk increasing drugs (FRIDs). However, deprescribing is not always attempte

Externí odkaz: https://doaj.org/article/3b36eed87dae44beb999460b538f65fa

Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 Diabetes (SCORE-IT): study protocol for the development of a core outcome set

Autor: Nicola L. Harman, John Wilding, Dave Curry, James Harris, Jennifer Logue, R. John Pemberton, Leigh Perreault, Gareth Thompson, Sean Tunis, Paula R. Williamson, on behalf of the SCORE-IT study team

Publikováno v: Trials, Vol 19, Iss 1, Pp 1-6 (2018)

Abstract Background Type 2 diabetes is characterised by abnormal glucose metabolism, and treatment is aimed at normalising glycaemia. Outcomes measured in clinical trials should be meaningful to patients, health care professionals and researchers, ye

Externí odkaz: https://doaj.org/article/2b7355a5ad5f40d493afd4406ffca9b3

Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 diabetes (SCORE- IT): A patient and healthcare professional consensus on a core outcome set for type 2 diabetes

Autor: Harman, N.L., Wilding, J.P.H., Curry, D., Harris, J., Logue, J., Pemberton, R.J., Perreault, L., Thompson, G., Tunis, S., Williamson, P.R., SCORE-IT Study Team (Gailus-Durner, V.), SCORE-IT Study Team (Raess, M.), SCORE-IT Study Team (Sanz-Moreno, A.)

Publikováno v: BMJ Open Diab. Res. Care 7:e000700 (2019)
BMJ Open Diabetes Research & Care

ObjectivesHeterogeneity in outcomes measured across trials of glucose-lowering interventions for people with type 2 diabetes impacts on the ability to compare findings and may mean that the results have little importance to healthcare professionals a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24054d28ffce86e30eb704780e40c987
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=57764

Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 Diabetes (SCORE-IT): study protocol for the development of a core outcome set

Autor: Leigh Perreault, Dave Curry, Jennifer Logue, Paula R Williamson, Sean Tunis, John P.H. Wilding, R John Pemberton, James Harris, Nicola Harman, Score-It Study Team, Gareth Thompson

Publikováno v: Trials
TRIALS
Trials, Vol 19, Iss 1, Pp 1-6 (2018)
on behalf of the SCORE-IT study team 2018, ' Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 Diabetes (SCORE-IT) : Study protocol for the development of a core outcome set ', Trials, vol. 19, no. 1, 427 . https://doi.org/10.1186/s13063-018-2805-2
Trials, 19(1):427. BioMed Central

Background Type 2 diabetes is characterised by abnormal glucose metabolism, and treatment is aimed at normalising glycaemia. Outcomes measured in clinical trials should be meaningful to patients, health care professionals and researchers, yet there i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0ad8b1d2ce42ef36c56215fa96ddcb8
https://pubmed.ncbi.nlm.nih.gov/30086771

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.